20 Paid Clinical Research Studies in Palo Alto, California

TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B)

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called ARV-471) when given together with other medicines for the potential treatm

📍 Stanford Women's Cancer Center — Palo Alto, California

💵 For Sub-Study B: All participants will receive ARV-471 and a medicine called ribociclib.

Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)

The use of continuous glucose monitoring (CGM) in earlier data has inspired behavioral changes leading to improved adherence to an exercise plan in individuals and eating habits in

📍 Signos — Palo Alto, California

A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease

This study aims to evaluate the efficacy and safety of inebilizumab for the prevention of flare of Immunoglobulin G4-related disease (IgG4-RD).

📍 Viela Bio Investigative Site — Palo Alto, California

💵 All subjects will receive an initial tapering dose of glucocorticoids (GCs) to complete treatment of their active diseas

Pediatric ACL: Understanding Treatment Options

Pediatric ACL: Understanding Treatment Outcomes (PLUTO) is a multi-center, prospective cohort study. Specific aims of PLUTO are to evaluate the safety and comparative effectiveness

📍 Stanford University Medical Center — Palo Alto, California

Phenotype, Genotype & Biomarkers in ALS and Related Disorders

The goals of this study are: (1) to better understand the relationship between the phenotype and genotype of amyotrophic lateral sclerosis (ALS) and related diseases, including pri

📍 Stanford University — Palo Alto, California

The Lasting Change Study

The study approach is to leverage the most cutting-edge techniques of multi-omics biology, wearable physiology, and digital real-time psychology profiling and using machine learnin

📍 Stanford university — Palo Alto, California

Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors

This study incorporates alisertib, the small-molecule inhibitor of Aurora A activity, in the treatment of patients younger than 22 years of age. Patients with recurrent or refracto

📍 Lucille Packard Children's Hospital at Stanford University Medical Center — Palo Alto, California

💵 In addition, patients may receive irradiation according to best clinical management for local control of extra-CNS disea

A Randomized Controlled Trial of Coaching Into Care With VA-CRAFT to Promote Veteran Engagement in PTSD Care

Posttraumatic stress disorder (PTSD) afflicts many war Veterans, but often they are reluctant to seek help despite availability of effective treatments. Family members are key sour

📍 VA Palo Alto Health Care System, Palo Alto, CA — Palo Alto, California

Assessing Cognitive Decline at Home

Neuropsychiatric symptoms (NPS) refer to a range of mental and emotional issues that can be observed through how patients move, perform daily tasks, and express feelings on their f

📍 Clinical Excellence Research Center — Palo Alto, California

Stanford Center for Back Pain

The purpose of the Stanford Center for Back Pain is to investigate and characterize the mechanisms of four treatments for chronic low back pain. These interventions (research treat

📍 Stanford University — Palo Alto, California

Exploring Mindsets, Beliefs and Resilience Across the Cancer Experience

The goal of this clinical trial is to test the effect of digitally delivered programs on the health, wellbeing, and functioning of newly diagnosed cancer patients. Participants wi

📍 Stanford University — Palo Alto, California

💵 Participants will receive access to digital courses developed by experts at Stanford University.

SPRINT: Signature for Pain Recovery IN Teens

To identify biological and phenotypic prognostic markers of recovery vs. persistence of pain and functional disability in adolescents with chronic musculoskeletal pain.

📍 Stanford University — Palo Alto, California

Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform

Metabolic syndrome and resulting downstream health effects remains a growing health concern. In published trials, the use of continuous glucose monitoring (CGM) assists behavioral

📍 Signos — Palo Alto, California

An Objective Assessment Tool for Evaluating Functioning in Older Adults

The Investigators are seeking your consent to participate in research investigating the development of a mobile application that enhances physical and cognitive assessments. This

📍 Clinical Excellence Research Center — Palo Alto, California

Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for CPT-Text for PTSD

There is a pressing need to increase capacity to treat PTSD related to or exacerbated by the COVID-19 pandemic. Texting-based therapy holds promise to increase capacity and reduce

📍 Stanford University — Palo Alto, California

TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called ARV-471) when given together with other medicines for the potential treatm

📍 Stanford Women's Cancer Center — Palo Alto, California

💵 For Sub-Study A: All participants will receive ARV-471 and a medicine called abemaciclib.

Nicotinamide and Pyruvate for Open Angle Glaucoma: A Randomized Clinical Study

The objective of this study is to determine if a combination of oral nicotinamide and pyruvate (N\&P) can maintain eye health as compared to placebo while standard-of-care intraocu

📍 Stanford University Department of Ophthalmology — Palo Alto, California

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

This is a phase II study using risk and response-adapted therapy for low, intermediate and high risk classical Hodgkin lymphoma. Chemotherapy regimens will be based on risk group a

📍 Lucile Packard Children's Hospital Stanford University — Palo Alto, California

💵 High-risk patients will receive Adcetris® (brentuximab vedotin), etoposide, prednisone and Adriamycin® (doxorubicin) (AE

Study of CHS-114 in Participants With Advanced Solid Tumors

This is a Phase 1, open-label, first-in-human, dose-escalation and expansion study of CHS-114, a monoclonal antibody that targets CCR8, as a monotherapy in patients with solid tumo

📍 Stanford Cancer Center — Palo Alto, California

Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab

The most common types of mature B-cell lymphomas (MBLs) in children are Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL). Initial treatment cures 90% - 95% of childr

📍 Lucile Packard Children's Hospital /ID# 240854 — Palo Alto, California

💵 Participants will receive subcutaneous (SC) of epcoritamab.